I am a pediatric cardiologist who practices general pediatric cardiology. I also perform noninvasive electrophysiology, which includes tests such as electrocardiograms, treadmill exercise tests and event monitors.
I was inspired to pursue my career by my mother, who is a nurse practitioner. I love taking care of children and working with parents.
I helped establish the Syncope Clinic at Cincinnati Children’s Heart Institute and serve as its current director. I also helped develop the Safety, Quality, Value program within the Heart Institute, which plays a supporting role in furthering the Heart Institute’s leadership in clinical outcomes, experience, and value for patients and families.
In my research, I am studying ways to increase high-value care for pediatric patients, quality improvement and population health. My master’s degree in public health led me to this research area.
MD: University of Utah School of Medicine, Salt Lake City, UT, 2002.
Masters of Public Health: University of Utah School of Medicine, Salt Lake City, UT, 2002.
Residency: Pediatrics, University of North Carolina,Chapel Hill, NC, 2002-2006.
Fellowship: Pediatric Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2006-2009.
Fellowship: Pediatric Electrophysiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2009-2010.
Masters of Business Administration: Ross School of Business, University of Michigan, Ann Arbor, MI, 2013.
Pediatric electrophysiology; syncope; quality improvement and outcomes
Research population health; health equity; congenital heart disease
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Registry-based trials: a potential model for cost savings?. Cardiology in the Young. 2020; 30:807-817.
Angiotensin-Converting Enzyme Inhibitor Prescription for Patients With Single Ventricle Physiology Enrolled in the NPC-QIC Registry. Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease. 2020; 9.
Resource utilisation in paediatric patients with secundum atrial septal defects. Cardiology in the Young. 2020; 30:383-5.
Wearable cardioverter-defibrillators in pediatric cardiomyopathy: A cost-utility analysis. Heart Rhythm. 2020; 17:287-293.
Enhancing efficiency and scientific impact of a clinical trials network: The Pediatric Heart Network Integrated CARdiac Data and Outcomes (iCARD) Collaborative. Cardiology in the Young. 2019; 29:1121-1126.
Quality Improvement in Congenital Cardiac Disease. Anderson's Pediatric Cardiology. Philadelphia, PA: Elsevier; 2019.
Can noninvasive testing identify benign patterns of suggested pre-excitation on electrocardiogram?. Pacing and Clinical Electrophysiology. 2019; 42:904-909.
Development of a System to Measure and Improve Outcomes in Congenital Heart Disease: Heart Institute Safety, Quality, and Value Program. The Joint Commission Journal on Quality and Patient Safety. 2019; 45:495-501.
Prenatal heart block screening in mothers with SSA/SSB autoantibodies: Targeted screening protocol is a cost-effective strategy. Congenital Heart Disease. 2019; 14:221-229.
Cardiac Networks United: an integrated paediatric and congenital cardiovascular research and improvement network. Cardiology in the Young. 2019; 29:111-118.
Jeffrey B. Anderson, MD, MPH, MBA11/14/2022
Jeffrey B. Anderson, MD, MPH, MBA10/10/2022